Repurposing N,N-Dimethylacetamide (DMA), a Pharmaceutical Excipient, as a Prototype Novel Anti-inflammatory Agent for the Prevention and/or Treatment of Preterm Birth.

Gorasiya, Samir; Mushi, Juliet; Pekson, Ryan; Yoganathan, Sabesan; Reznik, Sandra E

Gorasiya, Samir; Mushi, Juliet; Pekson, Ryan; Yoganathan, Sabesan; Reznik, Sandra E.

Afiliação

Gorasiya S; Department of Pharmaceutical Sciences College of Pharmacy and Health Sciences St. John's University, Queens, NY 11439, United States.
Mushi J; Department of Obstetrics and Gynecology Westchester Medical Center, Valhalla, NY 10595, United States.
Pekson R; Departments of Medicine and Cardiology and Cell Biology Albert Einstein College of Medicine, Bronx, NY 10461, United States.
Yoganathan S; Department of Pharmaceutical Sciences College of Pharmacy and Health Sciences St. John's University, Queens, NY 11439, United States.
Reznik SE; Department of Pharmaceutical Sciences College of Pharmacy and Health Sciences St. John's University, Queens, NY 11439, United States.

Curr Pharm Des ; 24(9): 989-992, 2018.

Article em En | MEDLINE | ID: mdl-29384052

Assuntos

Acetamidas/farmacologia; Anti-Inflamatórios não Esteroides/farmacologia; Nascimento Prematuro/tratamento farmacológico; Nascimento Prematuro/prevenção & controle; Humanos

Palavras-chave

Gestation; N,N-dimethylacetamide; inflammation; lipopolysaccharide; nuclear factor kappa B; preterm birth.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anti-Inflamatórios não Esteroides / Nascimento Prematuro / Acetamidas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google